Vaccines

13 Jul 2020 Tonix Pharmaceuticals Enters into Research and Exclusive License Option Agreement with Kansas State University to Develop Vaccine Against COVID-19
13 Jul 2020 Pfizer and BioNTech Granted FDA Fast Track Designation for Two Investigational mRNA-based Vaccine Candidates Against SARS-CoV-2
08 Jul 2020 CEPI Expands Partnership with Clover Biopharmaceuticals to Rapidly Advance Development and Manufacture of COVID-19 Vaccine Candidate
08 Jul 2020 Novavax Announces $1.6 Billion Funding from Operation Warp Speed
07 Jul 2020 GSK and Medicago announce collaboration to develop a novel adjuvanted COVID-19 candidate vaccine
07 Jul 2020 Sinovac COVID-19 Vaccine Collaboration with Butantan Receives Approval from Brazilian Regulator for Phase III Trial
02 Jul 2020 Sorrento Announces Selection of T-VIVA-19™ as Targeted Protein Vaccine Candidate for SARS-CoV-2
01 Jul 2020 Johnson & Johnson Announces European Commission Approval for Janssen’s Preventive Ebola Vaccine
01 Jul 2020 Pfizer and BioNTech Announce Early Positive Data from an Ongoing Phase 1/2 Study of mRNA-based Vaccine Candidate Against SARS-CoV-2
30 Jun 2020 Meissa Vaccines Provides a Pipeline Update on Vaccine Candidates for COVID-19 and RSV
30 Jun 2020 INOVIO Announces Positive Interim Phase 1 Data For INO-4800 Vaccine for COVID-19
26 Jun 2020 Entos Pharmaceuticals Announces Selection of Lead DNA Vaccine Candidates for COVID-19 and a $4.2M Award to Move Forward with Phase I/II Human Trials
26 Jun 2020 ERC Belgium Submits Marketing Authorization Application to European Medicines Agency (EMA) for Glioblastoma Immunotherapy, SITOIGANAP
25 Jun 2020 Sinovac Receives Approval from China for its Quadrivalent Influenza Vaccine
24 Jun 2020 Immunovative Therapies and Mirror Biologics Announce US FDA Clearance of a Universal Anti-Viral Vaccine Phase I/II Clinical Trial for Healthy Elderly Adults
23 Jun 2020 Sanofi and Translate Bio Expand Collaboration to Develop mRNA Vaccines Across All Infectious Disease Areas
23 Jun 2020 First Participant Dosed in Phase 1 Clinical Study with VTP-300 Immunotherapeutic to Treat Chronically Infected Hepatitis B Patients
23 Jun 2020 Collaborative COVID-19 Vaccine Project Between ImmunoPrecise Antibodies Europe and LiteVax BV, Funded Through TRANSVAC2
22 Jun 2020 Merck Announces That V114, Its Investigational 15-valent Pneumococcal Conjugate Vaccine, Met Safety and Immunogenicity Objectives in Initial Phase 3 Studies in Adults
22 Jun 2020 Pfizer Announces Start of Four Phase 3 Clinical Trials for Investigational Vaccines
22 Jun 2020 VBI Vaccines Announces Data from VBI-1901 Presented at AACR 2020: Partial Response Observed, Promising Biomarker Strategy Identified
22 Jun 2020 50% Complete Response Rate Observed in YourVaccx™ Study for Patients with Metastatic Prostate Cancer was Presented at the AACR Virtual Annual Meeting II
20 Jun 2020 Clover Biopharmaceuticals Initiates Phase 1 Clinical Trial for COVID-19 Vaccine Candidate
18 Jun 2020 Codagenix Announces the Synthesis and Preliminary Safety of Scalable, Live-attenuated Vaccine Candidate Against COVID-19
18 Jun 2020 CureVac Receives Regulatory Approval from German and Belgian Authorities to Initiate Phase 1 Clinical Trial of its SARS-CoV-2 Vaccine Candidate

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top